Tehilla E Brander (Tehilla Brander)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 5

Top Topics

Pulmonary Embolism

Cross Sectional

Clinical Practice

Top Venues

JCO precision oncology

American journal of medical genetics. Part C, Seminars in medical genetics

Blood cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel I Nathan, Tehilla E Brander, Julie Gold, Deborah Paul, Paula Klein, Kit Cheng, Johnson M Liu, Bridget K Marcellino
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism. JCO precision oncology 8 (2024)
Santiago Thibaud, Ryan L Subaran, Scott Newman, Alessandro Lagana, David T Melnekoff, Saoirse Bodnar, Meghana Ram, Zachry Soens, William Genthe, Tehilla E Brander, Tarek H Mouhieddine, Oliver Van Oekelen, Jane Houldsworth, Hearn Jay Cho, Shambavi Richard, Joshua Richter, Cesar Rodriguez, Adriana Rossi, Larysa J Sanchez, Ajai Chari, Erin Laverne Moshier, Sundar Jagannath, Samir S Parekh, Kenan Onel
Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes. Blood cancer discovery (2024)
Daniel I Nathan, Tehilla E Brander, Julie Gold, Deborah Paul, Paula Klein, Kit Cheng, Johnson M Liu, Bridget K Marcellino
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism. JCO precision oncology 8 (2024)
Daniel I Nathan, Tehilla E Brander, Julie Gold, Deborah Paul, Paula Klein, Kit Cheng, Johnson M Liu, Bridget K Marcellino
Diagnostic and Practical Challenges in Applying National Comprehensive Cancer Network Guidelines for Suspected Pathogenic TP53 Mosaicism. JCO precision oncology 8 (2024)
Katherine L Bergstrom, Tehilla E Brander, Kelsey E Breen, Hetanshi Naik
Experiences from the epicenter: Professional impact of the COVID-19 pandemic on genetic counselors in New York. American journal of medical genetics. Part C, Seminars in medical genetics 187 (1) (2020)